Michael E. Fraser
Impact in
- Cancer Research top 5%
- Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Cancer Genomics and Diagnostics 6
-
- Prostate Cancer Treatment and Research 15
- Prostate Cancer Diagnosis and Treatment 10
- Co-authors
- Benjamin K. Tsang (11 shared papers)Robert Glen Bristow (21 shared papers)Xiaojuan Yan (3 shared papers)Xiaokui Yang (2 shared papers)Theodorus van der Kwast (14 shared papers)Brendan M. Leung (2 shared papers)Tao Bai (1 shared paper)Paul Christopher Boutros (18 shared papers)
- Journals
- BMC Bioinformatics (3 papers)Nature Communications (2 papers)European Urology Focus (2 papers)Oncogene (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Michael E. Fraser
48 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 408
- Oncology 498
- Urology 108
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 509
Countries citing papers authored by Michael E. Fraser
This map shows the geographic impact of Michael E. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Fraser more than expected).
Fields of papers citing papers by Michael E. Fraser
This network shows the impact of papers produced by Michael E. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Fraser. The network helps show where Michael E. Fraser may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Fraser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 217 | |
| 2 | p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. | 2003 | 167 |
| 3 | 2003 | 153 | |
| 4 | 2007 | 149 | |
| 5 | 2002 | 127 | |
| 6 | 2017 | 122 | |
| 7 | 2016 | 116 | |
| 8 | 2011 | 113 | |
| 9 | 2011 | 102 | |
| 10 | 2014 | 101 | |
| 11 | 2018 | 90 | |
| 12 | 2006 | 83 | |
| 13 | 2008 | 73 | |
| 14 | 2011 | 72 | |
| 15 | 2005 | 70 | |
| 16 | 2008 | 68 | |
| 17 | 2020 | 66 | |
| 18 | 2009 | 53 | |
| 19 | 2019 | 50 | |
| 20 | 2001 | 47 |
About Michael E. Fraser
Michael E. Fraser is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 50 papers that have together received 2.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (10 papers), Cell death mechanisms and regulation (8 papers), Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (6 papers), Molecular Biology Techniques and Applications (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Cancer Research (408 citations), Oncology (498 citations), Urology (108 citations), Molecular Biology (1.3k citations) and Pulmonary and Respiratory Medicine (509 citations). Michael E. Fraser has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Benjamin K. Tsang, Robert Glen Bristow, Xiaojuan Yan, Xiaokui Yang, Theodorus van der Kwast, Brendan M. Leung, Tao Bai, Paul Christopher Boutros, Han C. Dan and Jin Quan Cheng. Their work appears in journals such as BMC Bioinformatics, Nature Communications, European Urology Focus, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.